Download full-text PDF

Source
http://dx.doi.org/10.1016/j.intimp.2022.109232DOI Listing

Publication Analysis

Top Keywords

corrigendum real-world
4
real-world study
4
study safety
4
safety extended
4
extended dosing
4
dosing schedule
4
schedule nivolumab
4
nivolumab pembrolizumab
4
pembrolizumab patients
4
patients solid
4

Similar Publications

Withdrawal notice to .

Lancet Reg Health Eur

September 2024

National Cancer Institute, IRCCS Fondazione G.Pascale, Naples, Italy.

Article Synopsis
  • The article with DOI: 10.1016/j.lanepe.2024.100973 is officially retracted.
  • The retraction indicates that the content is no longer valid or reliable.
  • For readers, this means they should disregard any information or conclusions presented in that article.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!